Original Source(s)
Related Content
Do Systemic Alpha-2 Agonists Lower Glaucoma Risk?
A large US cohort study found systemic alpha-2 agonist use was associated with a lower hazard of glaucoma-related diagnoses vs. beta-blockers.
July 8, 2026
-
3 min
Optegra Showcases Drop-Free Cataract Surgery Outcomes
Award-winning Optegra data on drop-free cataract surgery sparks interest at SECOIR 2026
June 11, 2026
-
2 min
VR Perimetry May Match HVF in Glaucoma
Virtual reality testing shortened visual field exams and was preferred among most patients in a retrospective study.
June 3, 2026
-
4 min